Diagnosis of ulcerative colitis and Crohn's disease using transabdominal ultrasonography

被引:1
|
作者
Kamano, Toshiaki [1 ]
Nakagawa, Yoshihito [1 ]
Nagasaka, Mitsuo [1 ]
Funasaka, Kohei [1 ]
Miyahara, Ryoji [1 ]
Hashimoto, Senju [1 ]
Shibata, Tomoyuki [1 ]
Hirooka, Yoshiki [1 ]
机构
[1] Fujita Hlth Univ, Dept Gastroenterol & Hepatol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi, Japan
关键词
Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Transabdominal ultrasonography; IMAGES;
D O I
10.1007/s10396-021-01181-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The following are some common features of ulcerative colitis (UC) and Crohn's disease (CD) on transabdominal ultrasonography (TUS). UC, which consists primarily of mucosal inflammation, is seen on TUS as wall thickening with preserved layer structure continuing from the rectum in the active phase of UC. Inflammation confined to the mucosa is seen as thickening of the mucosal/submucosal layers. When the inflammation becomes severe, the echogenicity of the submucosal layer decreases and the layer structure becomes indistinct. CD, which consists primarily of discontinuous transmural inflammation, shows more pronounced hypoechoic wall thickening than UC at the transmural inflammation. On TUS, the layer structure becomes indistinct and gradually disappears due to the depth of the myriad inflammation during the active phase of CD. It is important to evaluate the changes in wall thickening and layer structure when diagnosing UC and CD with TUS. In addition, diagnostic techniques such as color Doppler and contrast-enhanced ultrasonography, which can be used to assess blood flow, and elastography, which can be used to evaluate stiffness, are also used. Thus, TUS is a noninvasive and convenient modality that shows promise as a useful examination for diagnosis of UC and CD.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 50 条
  • [41] Inflammatory bowel disease (ulcerative colitis and Crohn's disease): Diagnostic criteria and differential diagnosis
    Winther, KV
    Fogh, P
    Thomsen, OS
    Brynskov, J
    DRUGS OF TODAY, 1998, 34 (11) : 935 - 942
  • [42] Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis
    Sartor, RB
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (07): : 390 - 407
  • [43] Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
    R Balfour Sartor
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 390 - 407
  • [44] Surgical therapy for ulcerative colitis and Crohn's disease
    Becker, JM
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1999, 28 (02) : 371 - +
  • [45] Mucosal metabolism in ulcerative colitis and Crohn's disease
    Duffy, MM
    Regan, MC
    Ravichandran, P
    O'Keane, C
    Harrington, MG
    Fitzpatrick, JM
    O'Connell, PR
    DISEASES OF THE COLON & RECTUM, 1998, 41 (11) : 1399 - 1405
  • [46] Differential therapy of ulcerative colitis and Crohn's disease
    Stange, EF
    LEBER MAGEN DARM, 1999, 29 (05) : 221 - 226
  • [47] The role of filgotinib in ulcerative colitis and Crohn's disease
    Fanizza, Jacopo
    D'Amico, Ferdinando
    Lauri, Gaetano
    Martinez-Dominguez, Samuel J.
    Allocca, Mariangela
    Furfaro, Federica
    Zilli, Alessandra
    Fiorino, Gionata
    Parigi, Tommaso Lorenzo
    Radice, Simona
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    IMMUNOTHERAPY, 2024, 16 (02) : 59 - 74
  • [48] Psychopathological aspects in Crohn's disease and ulcerative colitis
    Tobon, Sergio
    Vinaccia, Stefano
    Margarita Quiceno, Japcy
    Sandin, Bonifacio
    Nunez Rojas, Ariel Cesar
    AVANCES EN PSICOLOGIA LATINOAMERICANA, 2007, 25 (02): : 83 - 97
  • [49] Crohn's disease and ulcerative colitis in the same family
    Maté-Jiménez, J
    Ekbom, A
    Pajares-García, JM
    López-Nava, G
    Sandborn, WJ
    Gomollón, F
    DRUGS OF TODAY, 2001, 37 : 229 - 230